MLL1-pioneered H3K4me3 modification on KLF7 promoter accelerates the invasion of fibroblast-like synoviocytes in rheumatoid arthritis
- PMID: 41483084
- DOI: 10.1007/s11626-025-01096-1
MLL1-pioneered H3K4me3 modification on KLF7 promoter accelerates the invasion of fibroblast-like synoviocytes in rheumatoid arthritis
Abstract
This study aims to elucidate the role of mixed lineage leukemia 1 (MLL1) in regulating the invasion of fibroblast-like synoviocytes (FLSs) in rheumatoid arthritis (RA). RA-FLSs and HC-FLSs were isolated and cultured from synovial tissues of RA patients and healthy controls (HC). MLL1 knockdown was achieved in RA-FLSs using shRNA transfection. The expression of MLL1, Krüppel-like factor 7 (KLF7), and ubiquitin carboxyl-terminal hydrolase 7 (USP7) was assessed via quantitative real-time polymerase chain reaction (qRT-PCR) or Western blot. Cell proliferation and invasion were evaluated using cell counting kit-8 (CCK-8) and Transwell assays. Chromatin immunoprecipitation (ChIP) assays were conducted to determine the enrichment of MLL1 and histone H3 lysine 4 trimethylation (H3K4me3) at the KLF7 promoter and the binding of KLF7 to the USP7 promoter. A dual-luciferase assay was used to validate the transcriptional activation of USP7 by KLF7. Results demonstrated that MLL1 was significantly overexpressed in RA-FLSs, and its inhibition suppressed FLS proliferation and invasion. Mechanistically, MLL1 promoted KLF7 transcription through H3K4me3 modification, and KLF7 subsequently upregulated USP7 expression. These findings reveal a novel MLL1/KLF7/USP7 regulatory axis that facilitates RA-FLS invasion and may represent a potential therapeutic target in RA.
Keywords: Fibroblast-like synoviocytes; H3K4me3; Invasion; MLL1; Rheumatoid arthritis.
© 2026. The Society for In Vitro Biology.
Conflict of interest statement
Declarations. Ethical approval: The informed consent from all participants was obtained, and the study procedure was approved by the Ethics Committee of Shanghai Fengxian Central Hospital. Conflict of interest: The authors declare no competing interests.
References
-
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581
-
- Araki Y, Mimura T (2016) The mechanisms underlying chronic inflammation in rheumatoid arthritis from the perspective of the epigenetic landscape. J Immunol Res 2016:6290682 - DOI
-
- Araki Y, Mimura T (2017) The histone modification code in the pathogenesis of autoimmune diseases. Mediators Inflamm 2017:2608605 - DOI
-
- Araki Y, Aizaki Y, Sato K, Oda H, Kurokawa R, Mimura T (2018) Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts. Clin Exp Rheumatol 36(2):314–316
-
- Barik RR, Bhatt LK (2021) Emerging epigenetic targets in rheumatoid arthritis. Rheumatol Int 41(12):2047–2067 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
